These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6452036)

  • 1. Growth hormone secretion in neurological disorders.
    Martinez-Campos A; Giovannini P; Cocchi D; Zanardi P; Parati EA; Caraceni T; Müller EE
    Adv Biochem Psychopharmacol; 1981; 28():521-40. PubMed ID: 6452036
    [No Abstract]   [Full Text] [Related]  

  • 2. Regulatory peptides in animal paradigms of neuropsychiatric illness.
    Diamond BI; Borison RL
    Adv Biochem Psychopharmacol; 1982; 33():541-8. PubMed ID: 6214928
    [No Abstract]   [Full Text] [Related]  

  • 3. Endurance exercise modulates levodopa induced growth hormone release in patients with Parkinson's disease.
    Müller T; Welnic J; Woitalla D; Muhlack S
    Neurosci Lett; 2007 Jul; 422(2):119-22. PubMed ID: 17590511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of dopaminergic receptors in the regulation of growth hormone secretion.
    Müller EE; Liuzzi A; Cocchi D; Panerai AE; Oppizzi G; Lacatelli V; Mantegazza P; Silvestrini F; Chiodini PG
    Adv Biochem Psychopharmacol; 1977; 16():127-38. PubMed ID: 142419
    [No Abstract]   [Full Text] [Related]  

  • 5. Current concepts of abnormal motor disorder: an experimental model of attentional deficit disorder.
    Wray SR; Melville GN; Grell GA; Edge PC
    West Indian Med J; 1981 Sep; 30(3):107-18. PubMed ID: 6117153
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of carbidopa and L-dopa combination on the secretion of growth hormone in normal subjects and in patients with Parkinsonism].
    Nurzia A; Vacca U; Pirro R; Cerone G
    Clin Ter; 1975 Aug; 74(3):265-70. PubMed ID: 1227747
    [No Abstract]   [Full Text] [Related]  

  • 7. Pre- and postsynaptic action of bromocriptine: its pharmacological effects on shcizophrenia and neurological diseases.
    Trabucchi M; Andreoli VM; Frattola L; Spano PF
    Adv Biochem Psychopharmacol; 1977; 16():661-5. PubMed ID: 196497
    [No Abstract]   [Full Text] [Related]  

  • 8. The endocrinology of extrapyramidal system disorders.
    Kirkpatrick B; Tamminga CA
    Endocrinol Metab Clin North Am; 1988 Mar; 17(1):159-72. PubMed ID: 2967753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dopaminergic control of the diencephalo-pituitary axis for somatotropin secretion].
    Cavagnini F; Pontiroli AE; Raggi U; Peracchi M; Malinverni A
    Folia Endocrinol; 1973 Dec; 26(6):483-9. PubMed ID: 4801258
    [No Abstract]   [Full Text] [Related]  

  • 10. Animal models of Alzheimer's Parkinson's and Huntington's disease. A minireview.
    Antal A; Bodis-Wollner I
    Neurobiology (Bp); 1993; 1(2):101-22. PubMed ID: 8111350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolactin secretion as an index of brain dopaminergic function.
    Thorner MO; Login IS
    Adv Biochem Psychopharmacol; 1981; 28():503-20. PubMed ID: 6452035
    [No Abstract]   [Full Text] [Related]  

  • 12. Parkinson's disease and the adaptive capacity of the nigrostriatal dopamine system: possible neurochemical mechanisms.
    Hornykiewicz O
    Adv Neurol; 1993; 60():140-7. PubMed ID: 8420131
    [No Abstract]   [Full Text] [Related]  

  • 13. [Voice disorders caused by neurological diseases].
    Gamboa J; Jiménez-Jiménez FJ; Mate MA; Cobeta I
    Rev Neurol; 2001 Jul 16-31; 33(2):153-68. PubMed ID: 11562877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopaminergic and serotonergic regulation of growth hormone secretion in anorexia nervosa [proceedings].
    Halmi K; Sherman BS
    Psychopharmacol Bull; 1977 Jan; 13(1):63-5. PubMed ID: 319476
    [No Abstract]   [Full Text] [Related]  

  • 15. Is dopaminergic cell death accompanied by concomitant nerve plasticity?
    Anglade P; Blanchard V; Raisman-Vozari R; Faucheux BA; Herrero MT; Obeso JA; Mouatt-Prigent A; Kastner A; Strada O; Javoy-Agid F; Agid Y; Hirsch EC
    Adv Neurol; 1996; 69():195-208. PubMed ID: 8615129
    [No Abstract]   [Full Text] [Related]  

  • 16. Impaired behavioural and molecular adaptations to dopamine denervation and repeated L-DOPA treatment in Nur77-knockout mice.
    St-Hilaire M; Bourhis E; Lévesque D; Rouillard C
    Eur J Neurosci; 2006 Aug; 24(3):795-805. PubMed ID: 16930409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurotensin: role in psychiatric and neurological diseases.
    Cáceda R; Kinkead B; Nemeroff CB
    Peptides; 2006 Oct; 27(10):2385-404. PubMed ID: 16891042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Huntington's chorea and somatotropic hormone: dynamic explorations in 27 cases (author's transl)].
    Destée A; Petit H; Fossati P; Warot P
    Rev Neurol (Paris); 1981; 137(1):21-31. PubMed ID: 6453416
    [No Abstract]   [Full Text] [Related]  

  • 19. Neuroendocrinological studies of Parkinson disease.
    Kito S; Itoga E; Yamamoto M
    Hiroshima J Med Sci; 1984 Sep; 33(3):323-9. PubMed ID: 6511457
    [No Abstract]   [Full Text] [Related]  

  • 20. Dopamine dysregulation syndrome in Parkinson's disease patients: from reward to penalty.
    Bonci A; Singh V
    Ann Neurol; 2006 May; 59(5):733-4. PubMed ID: 16634013
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.